Euro-GASP external quality assessment scheme for Neisseria gonorrhoeae antimicrobial susceptibility testing – 2025

Source briefing · A concise briefing based on one linked source. It is intentionally shorter than a full FreedomWitness Evidence Engine analysis.

What the source reports

The 2025 Euro-GASP EQA scheme results confirm that participating laboratories continue to demonstrate a high level of competency in the recovery and susceptibility testing of N. gonorrhoeae.

With 27 countries participating and universal adherence to EUCAST guidelines, the network shows strong methodological consistency.

Evidence note: At this stage FreedomWitness is presenting what this source reports. This briefing does not independently prove every underlying claim and should be read together with the original material.

Source & verification

Primary source: Scientific and technical publications · July 28, 2026

Read the original source

FreedomWitness links to the original source so readers can inspect the underlying material and judge the context for themselves.